MN can be diagnosed in patients presenting with nephrotic syndrome and positive levels of PLA2R and THSD7A in the serum, but renal biopsy is uniquely informative in patients who are often PLA2R-negative and do not have typical nephrotic syndrome [4,30–32]. This evidence concerns the gene PLA2R1 and nephrotic syndrome.